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Background: Randia nilotica is known in northern Nigeria as Gial-goti, but has also been reported to be widespread 
in Sudan and India. The plant is used traditionally for its ethno-medicinal claims in managing mental-illnesses, 
convulsion or epilepsy, jaundice, infertility, snake bites and other ailments. The leaf, root and stem bark of the plant 
had been scientifically validated for CNS depressant activity and the stembark is particularly used for CNS-related 
disorders. However, information related to the toxicity potential of the plant is not available. 
Objective: To investigate the effect of 90-days administration of ethanol stem-bark extract of the plant on some 
physiological-biomarkers and vital-organs’ histology.   
Methods: Oral median-lethal dose (LD50) estimated from acute-toxicity test and extract doses of 250, 500, 1000mg/kg 
for 3-groups of 20-rats each and normal-saline control group were used. The rats were euthanized on the 90th-day 
following daily oral treatments per-body-weight. Blood-samples in plain and anticoagulated (EDTA) sample-bottles 
for biochemical and haematological analyses were collected from each group and vital-organs isolated, weighed and 
kept in fixatives for histo-analyses.  
Result: The oral acute extract-administration up to 5000mg/kg caused no observable toxic-sign or mortality.  PCV, Hb 
and RBC counts decreased significantly at 500 and 1000mg/kg, but only at 1000mg/kg for MCV, with no significant 
changes in other haematological-indices. Significant increase in blood-urea-nitrogen at all test-doses and in high-
density lipoprotein at 250mg/kg occurred. Brain-weight was significantly decreased and all organs histologically 
showed blood-vessels congestion and inflammatory-cells’ infiltration, in addition to dose-dependent neuronal-
degeneration and cerebral-oedema in brain, lymphocytes’ depletion in spleen, necrositic-hepatocytes, myocardial-
haemorrhage with oedematous-fragmentations and glomerular-atrophy, haemorrhage, tubular-necrosis, glomerular 
hypercellular-vacuolation and Bowman’s-capsule adhesion to parietal surface. 
Conclusion: Haematological, biochemical and histological analysis revealed evidence of chronic toxicity to various 
major organ systems. In addition to dose, duration of use also contributes to the toxic effects of the plant.  
Key-words: Randia-nilotica, stem-bark, ethanol extract, chronic-toxicity, rats 
Received: June, 2017  
Published: August, 2017 
 
1. Introduction 
The dose-related toxicity evaluation of extracts of 
natural products often provides valid information 
related to their biochemical, physiological and 
pharmacological effects on vital organs and their 
processes. It also provides an estimate of safety margin 
for initial safe starting dose of agents for clinical trials 
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(Robbinson et al, 2009). The routine toxicity 
evaluations which are often used in screening new 
chemical agents include the acute, sub-acute and 
chronic toxicity studies (Gupta et al, 2012).   The 
practice of using medicinal plants to maintain and 
promote health, prevent and/or cure a wide variety of 
diseases is being carried out over ages (Siddharthan, 
2007; Madhulika, 2010).  Quite a number of medicinal 
plants used traditionally or locally have proven to be 
important sources of potential therapeutic agents, but 
most often little or no attention is given in identifying 
the toxic effects associated with their use for relatively 
prolonged periods at both low and high doses.   
Randia nilotica (Stapf.) of the family, Rubiaceae and 
genus, catunaregam has common names as Xeromphis 
nilotica or Catunaregam nilotica and is known in the 
northern part of Nigeria as barbaji, tsibra, kwanarya or 
Gial-goti ((Dalziel, 1937; Burkill, 1985). It is used 
traditionally in many countries including Sudan, India 
and Northern Nigeria for mental illness, convulsion, 
epilepsy, jaundice, anti-infertility and for snake bites 
amongst other uses (Chabra et al, 1991; Ismaila et al, 
2012).  The leaf, root and stem bark of the plant had 
been scientifically validated for CNS depressant activity 
(Lemmich et al, 1995; Danjuma, et al, 2009). However, 
aside the acute toxicity studies, variously reported by 
the different researchers, no intensive toxicity study 
(sub-chronic or chronic) on the medicinal use of any 
part of Randia nilotica had been reported. This study 
thus, evaluated the toxicity profile of the stem bark of 
this plant in rats. 
2. Methods 
2.1 Collection, identification and extraction of the 
plant material 
The plant Randia nilotica was collected from 
Galadimawa village in Giwa Local Government of 
Kaduna State, Nigeria in the month of April, 2013. It was 
identified and authenticated with Voucher Specimen 
Number 2867 and deposited for reference purposes in 
the herbarium section of the department of Biological 
sciences, Ahmadu Bello University, Zaria. The stem bark 
of Randia nilotica was cleaned and air-dried under a 
shade to a constant weight and then pounded into 
coarse powder using pestle and mortar. The obtained 
1000 g powder was cold macerated into 2.5 litres of 70 
% ethanol for 72 hours and filtered. The filtrate was 
concentrated at 40oC over an evaporating dish and 
digital thermostatic water bath and it yielded 56.28 g 
(5.6%) brownish sticky solid residue. Working 
concentrations of 250, 500 and 1000 mg/kg extract 
doses were prepared fresh for each day experiment 
with distilled water. 
2.2 Experimental animals 
Male Wistar rats weighing between 120 – 280 g 
obtained from the Animal House Facility of the 
Department of Pharmacology and Therapeutics, 
Ahmadu Bello University, Zaria were used. The animals 
were maintained on standard rodents’ feed and liberal 
drinking water. The animals were handled in 
accordance with the ethical standards of the 
Department’s experimental animal committee which 
approved the study and also in accordance with the 
regulation for the Care and Use of Laboratory animals 
as accepted internationally (NIH, rev 1996).  
2.3 Acute toxicity study for LD50 determination 
The LD50 of the extract was determined using Lorke’s 
method (1983) of acute toxicity test.  A total of 13 rats 
were used to assess the extract for acute toxic effect of 
phases I and II of this model and of which 9 rats in 3 
study groups of 3 per group were given graded doses of 
10, 100 and 1000 mg/kg respectively in the 1st phase 
test and observed for death in 24 hours. Increased 
doses of 800, 1600, 2,900 and 5,000 mg/kg in absence 
of mortality in first phase were administered to the 
remaining rats in study groups of 1 rat per group. From 
the observed outcome, the LD50 was then calculated as 
the geometric mean of the highest non-lethal dose and 
the lowest lethal dose. 
2.4 Chronic toxicity study 
The repeated dose of 90 days oral toxicity study of the 
organization of Economic Cooperation and 
Development Guidelines (OECD GLs) 408 of 1998, in 
male Wister rats was used for chronic effect 
investigations.  Four groups of 20 rats of both sexes, 
matched for weight and sex per group were orally pre-
treated daily for 90 days with normal saline (group 1) 
and extract doses of 250, 500 and 1000 mg/kg for 
groups 2-4.  Blood samples collected at the end of 
treatment periods of 90 days from each rat-group into 
plain and anticoagulated (EDTA) sample-bottles were 
used for biochemical and haematological analyses 
respectively. The brain, heart, kidney, liver and spleen 
isolated from the euthanized rats were weighed and 
fixed in 10 % buffered formalin or Bouin’s fluid (brain 
only) for histopathological examinations. The 
parameters evaluated for toxic effects of the plant 
extract include aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), and alkaline 
phosphatase (ALP) levels, blood urea nitrogen (BUN), 
creatinine, calcium, total protein (TP), albumin, total 
cholesterol (TC), triglyceride (TG) and high density 
lipoprotein (HDL); packed cell volume (PCV), 
haemoglobin (Hb), red blood cell (RBC) count, mean 
corpuscular haemoglobin concentration (MCHC), mean 
cell haemoglobin (MCH), mean cell volume (MCV), 
white blood cell count (WBC) and differentials – 
neutrophils, lymphocytes, monocytes, basophils, 
eosinophils; erythrocytes sedimentation rate (ESR); 
organ-weight variation and histological analysis of the 
brain, heart, kidney, liver and spleen. 
2.5 Statistical analysis 
Data were expressed as mean ± standard error of mean 
(M±SEM) and results presented as tables and figures. 
Data were analyzed using one way Analysis of variance 
(ANOVA) followed by Post-Hoc Dunnett’s test for 
multiple comparisons at the significance level of p<0.05.  
3. Results  
The oral median lethal dose (LD50) estimation  
There were no observable toxic signs or mortality at up 
to 5000 mg/kg body-weight oral administration of the 
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extract. Oral median lethal dose (LD50) was thus 
estimated to be greater than 5000 mg/kg. 
Effect of 90 days daily oral administration of 
ethanol extract of Randia nilotica on haematological 
and biochemical parameters in rats 
The result of the haematological analysis in Table 1 
below showed significant (p<0.05) decrease in PCV, Hb 
and RBC counts at both 500 and 1000 mg/kg extract 
doses. The mean cell volume (MCV) was also 
significantly (p<0.05) increased, but only at 1000 
mg/kg.  
The biochemical analysis showed that the 90 days daily 
oral administration of ethanolic stem bark extract of 
Randia nilotica caused significant (p<0.05) increase in 
blood urea nitrogen at all tested doses and also in high 
density lipoprotein (HDL), but only at 250 mg/kg of 
extract dose (Table 2). 
 
Table 1: Haematological parameters in 90 days treated rats with ethanol stem bark extract of Randia nilotica 
Haematological 
indices 
Distilled water 
(1 ml/kg) 
Extract doses (mg/kg) 
RNE 250 RNE 500 RNE 1000 
PCV (%) 40.75 ± 1.23 41.39  ± 1.85 26.20 ± 3.60* 26.50 ± 3.50*  
Hb (g/dl) 13.32 ± 0.39 13.61 ± 0.60 8.50 ± 1.20* 8.65 ± 1.35* 
RBC(1012/l) 4.77 ± 0.17 4.97 ± 0.23 3.08 ± 0.51* 2.90 ± 0.40* 
MCHC(g/dl) 32.40 ± 0.29 40.69 ± 5.27 32.20 ± 0.37 32.50 ± 0.50 
MCH(pg) 28.15 ± 0.23 27.62 ± 0.21 28.60 ± 0.75 30.00 ± 1.00 
MCV (fl) 85.35 ± 0.55 83.08 ± 0.54 86.20 ± 2.94 91.50 ± 0.50* 
Neutrophils (%) 25.65 ± 1.25 28.46 ± 0.91 27.40 ± 1.72 26.50 ± 3.50 
Lymphocytes (%) 72.20 ± 1.26 68.62 ± 1.15 72.00 ± 1.64 73.00 ± 3.00 
Monocytes (%) 2.00 ± 0.27 2.33 ± 0.33 1.00 ± 0.00 0.00 ± 0.00 
Eosinophils (%) 3.00 ± 0.47 3.44 ± 0.29 2.00 ± 0.00 1.00 ± 0.00 
WBC (109/l) 14.53 ± 0.87 14.94 ± 1.20 11.02 ± 2.14 8.95 ± 0.35 
Platelets (109/l) 229.37 ± 8.94 256.31 ± 19.57 175.20 ± 10.37 170.50 ± 2.50 
Data are presented as Mean±SEM; * = One-way ANOVA and Dunnett’s post hoc test at p<0.05 n=20; RNE= Randia nilotica extract. 
 
Table 2: Biochemical indices following 90 days daily oral administration of ethanolic stem bark extract of Randia 
Nilotica in rats 
 
Liver Indices 
Treatments(mg/kg) 
Distilled Water (1ml/kg) RNE 250 RNE 500 RNE 1000 
AST (u/l) 64.16±3.63 63.31±4.55 73.60±4.89 66.00±20.00 
ALT (u/l) 70.32±3.84 70.85±5.21 87.00±5.65 72.50±21.50 
ALP (u/l) 85.00±4.38 103.46±8.77 113.00±11.81 90.50±31.50 
ALBUMIN (g/l) 37.00±0.64 37.33±1.18 39.80±0.66 42.00±0.00 
TP (g/l) 64.94±0.87 66.67±1.28 65.50±1.85 67.00±0.00 
Triglyceride(mg/dl) 0.85±0.05 0.91±0.06 0.88±0.08 1.15±0.15 
HDL (mg/dl) 0.78±0.04 0.99±0.05* 0.76±0.07 0.85±0.05 
TC (mg/dl) 2.38±0.05 2.39±0.07 2.60±0.12 2.75±0.55 
LDL (mg/dl) 1.42±0.06 1.22±0.10 1.66±0.08 1.67±0.57 
Data are presented as mean±SEM; * = One-way ANOVA and Dunnett’s post hoc test at p<0.05 n=20; RNE = Randia nilotica extract 
 
Effect of ethanolic stem bark extract of Randia 
nilotica on organ weights and histology 
Changes in organ weights relative to control group 
following 90 days daily oral administration were not 
significant. However, there was statistically significant 
decrease in brain weight at the various doses (Table 3). 
Histological assessment of organs following 90 days 
oral administration of Randia nilotica stem bark extract 
revealed neuronal degeneration, blood vessel and 
cerebral congestions in the brain. The kidney showed 
glomerular atrophy, haemorrhage, tubular-necrosis, 
Bowman’s capsule adhesion to parietal cells, 
hypercellular-vacuolation, inflammatory cells’ 
infiltration and glomerular-congestion (Figure 1). 
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Table 3: Organ weight changes following 90 days daily oral administration of stem bark extract of Randia nilotica in 
rats 
Organs (g) 
Distilled water 
(1 ml/kg) 
Doses (mg/kg) 
RNE 250 RNE 500 RNE 1000 
Heart 0.54 ± 0.54 0.54 ± 0.03 0.55 ± 0.07 0.58 ± 0.03 
Spleen 0.57 ± 0.04 0.61 ± 0.06 0.77 ± 0.06 0.60 ± 0.00 
Liver 4.17 ± 0.11 4.37 ± 0.24 4.72 ± 0.71 4.70 ± 0.20 
Kidney 0.81 ± 0.03 0.81 ± 0.06 0.98 ± 0.11 0.90 ± 0.01 
Brain 1.72 ± 0.04 1.50 ± 0.07* 1.42 ± 0.11* 1.30 ± 0.10* 
Data are presented as mean±SEM; * = One-way ANOVA and Dunnett’s post hoc test at p<0.05  n=20; RNE = Randia nilotica extract 
 
Organ Normal Saline 250 mg/kg 500 mg/kg 1000 mg/kg 
Brain 
    
Heart 
    
Spleen 
    
Kidney 
    
Liver 
    
 
Figure 1: Photomicrographs of organ sections (H & E at × 200 – 400) of rats following 90 days daily oral 
administration of ethanol stem bark extract of Randia nilotica showing: Congestion (a); Haemorrhage (b); Oedema 
(c); Fragmentation of muscle fibres (d); Depletion of lymphocytes (e); Hypertrophy of glomeruli (f); Vacuolation of 
glomeruli (g); inflammatory cells infiltration (h); Necrosis of hepatocytes (i).  
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4.0 Discussion 
This study revealed that Randia nilotica stem bark 
extract used traditionally for various diseases is 
practically non-toxic at up to and above 5000 mg/kg 
dose from acute oral administration. This was in line 
with the documentation of Lorke (1983) that 
compounds with an oral LD50 above 5000 mg/kg body 
weight are practically non toxic  
In an earlier sub-chronic toxicity study of 28 days daily 
oral administration, only the packed cell volume (PCV) 
was significantly (p<0.05) decreased and at 1000 mg/kg 
extract dose. However, in this study of 90 days daily 
oral administration for chronic toxicity evaluation, the 
PCV was significantly decreased even at 500 mg/kg 
dose and together with other related haematologic 
indices such as Hb and RBC counts, but the MCV was 
increased significantly at 1000 mg/kg.  
The packed (or red blood) cell volume (PCV) also 
known as haematocrit is the volume percentage (%) of 
red blood cells in blood that serves as a reference point 
of capability of RBCs to deliver oxygen.  It is usually an 
integral part of complete blood cell counts, along with 
haemoglobin concentration, white blood cell count, and 
platelet count. For a condition such as anaemia that 
goes unnoticed, one way it can be diagnosed is by 
measuring the haematocrit levels of the blood which 
shows the number of red blood cells in circulation 
(Adewuyi, 2007).  Low levels of it suggest reduced 
transportation of oxygen (or blood flow) from the lungs 
to the body tissues. This usually is indicative of certain 
problems including iron deficiency, haemorrhage, or 
kidney dysfunction amongst other ailment conditions 
(Katzung et al, 2009; Camaschella, 2015). The red cells 
contain Hb that oxygenates blood in the lungs and a 
deficiency of red cells or its Hb (aplastic anaemia) 
occurs in conditions of iron lack because iron is the 
principal element in Hb for blood production. Thus, a 
low haematocrit as with reduced red cell sizes or low 
mean corpuscular volume (MCV) suggests chronic iron-
deficiency anaemia with consequent abnormal 
haemoglobin synthesis (Camaschella, 2015). A decrease 
in the concentration of Hb as was observed in this study 
could be related to depletion in the essential body iron. 
Aside alkaline or high phosphate related reduction in 
the availability of iron, severe iron deficiency condition 
is often as a result of blood loss via bleeding; and 
haemorrhage and which were among the pathologic 
effects in the histological examinations of the various 
organs in this study. The two predominant sites of iron 
storage are the reticuloendothelial system and the 
hepatocytes, but some storage also occurs in the muscle.  
The main sites of reticuloendothelial cells are bone 
marrow, spleen, liver and lymphoid tissues and this 
study showed that the spleen had lymphocytes’ 
depletion and both the spleen and liver had blood-
vessels’ congestion. The liver also showed necrositic-
hepatocytes with perivascular infiltration of 
inflammatory cells.  These effects of the extract may 
have caused depletion in the body iron store. 
Myocardial haemorrhage and congestion with 
infiltration of inflammatory cells (myocarditis) also 
occurred and may have decreased the heart’s ability or 
efficiency to pump blood and this might have 
contributed to the reduction in these blood parameters 
and/or depletion in the muscle store of iron. Resistance 
in flow of blood from any condition often invariably 
increases the total vascular resistance to cause 
oedematous fragmentations of the muscle fibres 
(Guyton and Hall, 2006), as also observed in the heart.  
Significant decrease in brain weight was seen in the 90 
days daily oral administration of the stem bark extract 
of Randia nilotica in addition to histological changes 
that also occurred in the heart, kidney, spleen and liver. 
Neuronal degeneration, blood vessel and cerebral 
congestions occurred in the brain. The kidney showed 
glomerular atrophy, haemorrhage, tubular-necrosis, 
Bowman’s capsule adhesion to parietal cells, 
hypercellular-vacuolation, inflammatory cells’ 
infiltration and glomerular-congestion. The increased 
vulnerability to toxic attack often seen with both the 
kidney and liver is due to their involvement in many 
important physiological and pharmacological functions 
(Rang and Dale, 2007).  The liver is directly involved in 
the metabolism of most toxic agents and most times 
many of these agents undergo metabolic activation to 
form reactive metabolites in the process of metabolism. 
Plasma albumin and about 30% serum globulins are 
formed in the liver and it is also the site of urea cycle 
and creatinine synthesis amongst other functions 
(Marcovitch, 2005). Blood volume and electrolyte 
composition are regulated by the complex homeostatic 
mechanisms in which the kidneys reabsorb its 
important glomerular filtered materials and excretes 
many waste substances including urea, creatinine and 
albumin (Marcovitch, 2005). Kidney impairment often 
diminishes the glomerular filtration rate (GFR) of liver-
synthesized and other materials resulting in their 
retention (Chen et al, 2008; Ferguson et al, 2008, 
Treseler, 1995). Thus, the significant increase in blood 
urea-nitrogen (BUN) at all test doses of Randia nilotica 
extract may solely be related to kidney changes as liver 
damage can impair urea cycle. This finding probably 
suggests that the liver damage from this extract may not 
have been severe for such impairment.  Urea is the 
totality of the waste product of protein metabolism 
representing about 90% of the total urinary excreted 
nitrogen. Mild necrositic injuries of the hepatocytes may 
only elevate liver transaminase (ALT, AST) levels 
(Nyblom et al, 2004) and slight increase in these 
enzymes observed in this study was not significant.   
Significant increase in high density lipoprotein (HDL) 
level occurred at the 250 mg/kg dose in the 90 days 
daily oral administration of the stem bark extract of 
Randia nilotica with slight reduction in the low density 
lipoprotein (LDL). The HDLs secreted in the liver and 
small intestines decreases the clotting potentials of 
blood, participates in mopping of bad cholesterol from 
the arterial wall and also help to inhibit the oxidation of 
atherogenic or LDL lipoproteins (Akubue et al, 2006; 
Katzung et al, 2009).  HDL-Cholesterol also acts as an 
anti-inflammatory agent.   
5.0 Conclusion  
Haematological, biochemical and histological analysis 
revealed evidence of chronic toxicity to various major 
organ systems. The findings of this study also indicate 
that the time-course of exposure or duration of therapy 
is a major toxicological issue as is the dose or amount of 
agents taken. 
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